Search Results - "Barchiesi, F."

How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) by Arendrup, M.C., Friberg, N., Mares, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M.C., Meletiadis, J., Guinea, J., Friberg, N., Mares, M., Kahlmeter, G., Andersen, C.T., Arikan-Akdagli, S., Barchiesi, F., Chryssanthou, E., Hamal, P., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Matos, T., Muehlethaler, K., Rogers, T.R., Velegraki, A., Arikan, S.

“…EUCAST has revised the definition of the susceptibility category I from ‘Intermediate’ to ‘Susceptible, Increased exposure’. This implies that I can be used…”
Get full text

How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates by Guinea, J., Verweij, P.E., Meletiadis, J., Mouton, J.W., Barchiesi, F., Arendrup, M.C., Arendrup, M.C., Arikan-Akdagli, S., Barchiesi, F., Castanheira, M., Chryssanthou, E., Friberg, N., Guinea, J., Järv, H., Klimko, N., Kurzai, O., Lagrou, K., Lass-Flörl, C., Mares, M., Matos, T., Meletiadis, J., Moore, C.B., Mouton, J.W., Muehlethaler, K., Rogers, T.R., Andersen, C.T., Velegraki, A.

“…The emergence of azole-resistant Aspergillus fumigatus isolates is a matter of significant concern in Europe, with countries reporting resistance rates (which…”
Get full text

Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes by Arendrup, Maiken Cavling, Jørgensen, Karin Meinike, Guinea, Jesus, Lagrou, Katrien, Chryssanthou, Erja, Hayette, Marie-Pierre, Barchiesi, Francesco, Lass-Flörl, Cornelia, Hamal, Petr, Dannaoui, Eric, Chowdhary, Anuradha, Hare, Rasmus Krøger, Meletiadis, Joseph

Get full text

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial by Fabbiani, Massimiliano, Gagliardini, Roberta, Ciccarelli, Nicoletta, Quiros Roldan, Eugenia, Latini, Alessandra, d’Ettorre, Gabriella, Antinori, Andrea, Castagna, Antonella, Orofino, Giancarlo, Francisci, Daniela, Chinello, Pierangelo, Madeddu, Giordano, Grima, Pierfrancesco, Rusconi, Stefano, Del Pin, Barbara, Lombardi, Francesca, D’Avino, Alessandro, Focà, Emanuele, Colafigli, Manuela, Cauda, Roberto, Di Giambenedetto, Simona, De Luca, Andrea

“…Abstract Objectives To investigate the long-term safety and efficacy of a treatment switch to dual ART with atazanavir/ritonavir + lamivudine versus continuing…”
Get full text

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients by Montagna, M. T., Lovero, G., Coretti, C., Martinelli, D., Delia, M., De Giglio, O., Caira, M., Puntillo, F., D’Antonio, D., Venditti, M., Sambri, V., Di Bernardo, F., Barbui, A., Lo Cascio, G., Concia, E., Mikulska, M., Viscoli, C., Maximova, N., Candoni, A., Oliveri, S., Lombardi, G., Pitzurra, L., Sanguinetti, M., Masciari, R., Santantonio, T., Andreoni, S., Barchiesi, F., Pecile, P., Farina, C., Viale, P., Specchia, G., Caggiano, G., Pagano, L.

“…Purpose We compared the risk factors, the diagnostic tools and the outcome of filamentous fungal infections (FFIs) in hematological patients (HAEs) and…”
Get full text

International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole by ESPINEL-INGROFF, A, BARCHIESI, F, CUENCA-ESTRELLA, M, PFALLER, M. A, RINALDI, M, RODRIGUEZ-TUDELA, J. L, VERWEIJ, P. E

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature by Mazzocato, S., Marchionni, E., Fothergill, A. W., Sutton, D. A., Staffolani, S., Gesuita, R., Skrami, E., Fiorentini, A., Manso, E., Barchiesi, F.

“…A case of systemic infection due to Saprochaete capitata in a patient with chronic lymphocytic leukemia is described. A review of the literature was conducted…”
Get full text

Heterozygosis and pathogenicity of Cryptococcus neoformans AD-hybrid isolates by Cogliati, M, Barchiesi, F, Spreghini, E, Tortorano, Anna Maria

“…Nineteen Cryptococcus neoformans AD-hybrid isolates were investigated to assess whether hybrid genomic background could affect virulence in a mouse model. The…”
Get full text

Aspergillus spp. invasive external otitis: favourable outcome with a medical approach by Marchionni, E., Parize, P., Lefevre, A., Vironneau, P., Bougnoux, M.E., Poiree, S., Coignard-Biehler, H., DeWolf, S.E., Amazzough, K., Barchiesi, F., Jullien, V., Alanio, A., Garcia-Hermoso, D., Wassef, M., Kania, R., Lortholary, O., Lanternier, F.

“…Aspergillus spp. invasive external otitis (IEO) is a rare infection. We performed a seven-year, single-centre retrospective study from 2007 to 2014 including…”
Get full text

Osteomyelitis caused by Aspergillus species: a review of 310 reported cases by Gabrielli, E., Fothergill, A.W., Brescini, L., Sutton, D.A., Marchionni, E., Orsetti, E., Staffolani, S., Castelli, P., Gesuita, R., Barchiesi, F.

“…Aspergillus osteomyelitis is a rare infection. We reviewed 310 individual cases reported in the literature from 1936 to 2013. The median age of patients was 43…”
Get full text

Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts by Rodríguez-Tudela, J.L., Barchiesi, F., Bille, J., Chryssanthou, E., Cuenca-Estrella, M., Denning, D., Donnelly, J.P., Dupont, B., Fegeler, W., Moore, C., Richardson, M., Verweij, P.E.

Get full text

Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital by Bedini, A., Venturelli, C., Mussini, C., Guaraldi, G., Codeluppi, M., Borghi, V., Rumpianesi, F., Barchiesi, F., Esposito, R.

“…The epidemiological and antifungal susceptibility data for 94 episodes of candidaemia in an Italian tertiary-care hospital between January 2000 and August 2003…”
Get full text

Epidemiology and Microbiology of Surgical Wound Infections by GIACOMETTI, A, CIRIONI, O, SCHIMIZZI, A. M, DEL PRETE, M. S, BARCHIESI, F, D'ERRICO, M. M, PETRELLI, E, SCALISE, G

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals by Orsetti, E., Staffolani, S., Gesuita, R., De Iaco, G., Marchionni, E., Brescini, L., Castelli, P., Barchiesi, F.

“…Background Chronic hepatitis C virus (HCV) infection has become a leading cause of non-acquired immunodeficiency syndrome (AIDS)-related morbidity and…”
Get full text

Reply to Ma et al.: Osteomyelitis caused by Aspergillus species by Gabrielli, E., Fothergill, A.W., Brescini, L., Sutton, D.A., Marchionni, E., Orsetti, E., Staffolani, S., Castelli, P., Gesuita, R., Barchiesi, F.

Get full text

Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) by Cuenca-Estrella, M., Moore, C.B., Barchiesi, F., Bille, J., Chryssanthou, E., Denning, D.W., Donnelly, J.P., Dromer, F., Dupont, B., Rex, J.H., Richardson, M.D., Sancak, B., Verweij, P.E., Rodríguez-Tudela, J.L.

“…To evaluate the intra- and inter-laboratory reproducibility of a new standard for susceptibility testing of fermentative yeasts. This standard is based on the…”
Get full text

In Vitro Susceptibility Tests for Cationic Peptides: Comparison of Broth Microdilution Methods for Bacteria That Grow Aerobically by Giacometti, A, Cirioni, O, Barchiesi, F, Del Prete, M S, Fortuna, M, Caselli, F, Scalise, G

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

In vitro activity of the lipopeptide derivative (Pal-lys-lys-NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes by Simonetti, O., Arzeni, D., Ganzetti, G., Silvestri, C., Cirioni, O., Gabrielli, E., Castelletti, S., Kamysz, W., Kamysz, E., Scalise, G., Offidani, A., Barchiesi, F.

“…Summary Background  An increasing number of antimycotics have become available for the treatment of dermatophytoses; however, there are reports suggesting…”
Get full text

Comparison of Visual 24-Hour and Spectrophotometric 48-Hour MICs to CLSI Reference Microdilution MICs of Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Candida spp.: a Collaborative Study by Espinel-Ingroff, A, Barchiesi, F, Cuenca-Estrella, M, Fothergill, A, Pfaller, M. A, Rinaldi, M, Rodriguez-Tudela, J. L, Verweij, P. E

“…A multicenter (six-center) study evaluated the performance (interlaboratory reproducibility, compatibility with reference methods, and categorical agreement)…”
Get full text

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp by Kamysz, E., Simonetti, O., Cirioni, O., Arzeni, D., Ganzetti, G., Campanati, A., Giacometti, A., Gabrielli, E., Silvestri, C., Kamysz, W., Offidani, A., Barchiesi, F.

“…▶ We think that our results are interesting since synergy between PAL and CAS might be useful in clinic trails to treat invasive fungal infections. Candida…”
Get full text